Crohn's disease: FDA reporting patterns
64,835 FDA FAERS reports mention Crohn's disease. 57,180 reports have a serious outcome flag.
Medicines named as suspect
- Adalimumab: 22,749 reports
- Infliximab: 11,451 reports
- Vedolizumab: 10,917 reports
- Ustekinumab: 5,116 reports
- Certolizumab Pegol: 3,697 reports
- Methotrexate: 3,051 reports
- Isotretinoin: 2,806 reports
- Risankizumab: 2,072 reports
- Prednisone: 1,744 reports
- Etanercept: 1,725 reports
- Azathioprine: 1,491 reports
- Mesalamine: 1,421 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.